Balogh JM, Sutherland SE (1989) Osteoradionecrosis of the mandible: a review. J Otolaryngol 18(5):245–250

CAS  PubMed  Google Scholar 

Nadella KR, Kodali RM, Guttikonda LK, Jonnalagadda A (2015) Osteoradionecrosis of the jaws: clinico-therapeutic management: a literature review and update. J Maxillofacial Oral Surg 14(4):891–901

Article  Google Scholar 

Landesberg R, Woo V, Cremers S, Cozin M, Marolt D, Vunjak-Novakovic G, Kousteni S, Raghavan S (2011) Potential pathophysiological mechanisms in osteonecrosis of the jaw. Ann N Y Acad Sci 1218(1):62–79

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shibahara T (2019) Antiresorptive agent-related osteonecrosis of the jaw (ARONJ): a twist of fate in the bone. Tohoku J Exp Med 247(2):75–86

Article  CAS  PubMed  Google Scholar 

Hoefert S, Hoefert CS, Widmann M (2015) History of osteonecrosis of the jaw. In: Otto S (ed) Medication-related osteonecrosis of the jaws. Springer

Google Scholar 

Sigua-Rodriguez EA, da Costa RR, de Brito AC, Alvarez-Pinzon N, de Albergaria-Barbosa JR (2014) Bisphosphonate-related osteonecrosis of the jaw: a review of the literature. Int J Dentistry. https://doi.org/10.1155/2014/192320

Article  Google Scholar 

Pimolbutr K, Porter S, Fedele S (2018) Osteonecrosis of the jaw associated with antiangiogenics in antiresorptive-naive patient: a comprehensive review of the literature. Biomed Res Int 23:2018

Google Scholar 

Pakosch D, Papadimas D, Munding J, Kawa D, Kriwalsky MS (2013) Osteonecrosis of the mandible due to anti-angiogenic agent, bevacizumab. Oral Maxillofac Surg 17(4):303–306

Article  PubMed  Google Scholar 

Lombard T, Neirinckx V, Rogister B, Gilon Y, Wislet S (2016) Medication-related -osteonecrosis of the jaw: new insights into molecular mechanisms and cellular therapeutic approaches. Stem Cells Int 18:2016

Google Scholar 

Schwartz HC. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update and CTX. Journal of Oral and Maxillofacial Surgery. 2015 Mar 1;73(3):377.

Article  PubMed  Google Scholar 

Lyons A, Ghazali N (2008) Osteoradionecrosis of the jaws: current understanding of its pathophysiology and treatment. Br J Oral Maxillofac Surg 46(8):653–660

Article  PubMed  Google Scholar 

Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O’Ryan F (2014) Medication-related osteonecrosis of the jaw—2014 Update. J Oral Maxillofac Surg 72(10):1938–1956

Article  PubMed  Google Scholar 

Ravindran Rathy SS, Nivia M (2013) Osteoradionecrosis of mandible: case report with review of literature. Contemporary Clin Dentistry 4(2):251

Article  Google Scholar 

Wan JT, Sheeley DM, Somerman MJ, Lee JS (2020) Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors. Bone Res 8(1):1–2

Article  Google Scholar 

Fan H, Kim SM, Cho YJ, Eo MY, Lee SK, Woo KM (2014) New approach for the treatment of osteoradionecrosis with pentoxifylline and tocopherol. Biomater Res 18(1):1

Article  Google Scholar 

Ajila V, Hegde S (2020) Osteoradionecrosis-a review of clinical features and management. Gülhane Tip Dergisi 62(4):213

Google Scholar 

Chronopoulos A, Zarra T, Ehrenfeld M, Otto S (2018) Osteoradionecrosis of the jaws: definition, epidemiology, staging and clinical and radiological findings. Concise Rev Int Dental J 68(1):22–30

Article  Google Scholar 

Devi S, Singh N (2014) Dental care during and after radiotherapy in head and neck cancer. Nat J Maxillofacial Surg 5(2):117

Article  Google Scholar 

Hong TS, Ritter MA, Tome WA, Harari PM (2005) Intensity-modulated radiation therapy: emerging cancer treatment technology. Br J Cancer 92(10):1819–24

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chrcanovic BR, Reher P, Sousa AA, Harris M (2010) Osteoradionecrosis of the jaws—a current overview—part 2: dental management and therapeutic options for treatment. Oral Maxillofac Surg 14(2):81–95

Article  PubMed  Google Scholar 

Marx RE (1983) Osteoradionecrosis: a new concept of its pathophysiology. J Oral Maxillofac Surg 41(5):283–288

Article  CAS  PubMed  Google Scholar 

Sultan A, Hanna GJ, Margalit DN, Chau N, Goguen LA, Marty FM, Rabinowits G, Schoenfeld JD, Sonis ST, Thomas T, Tishler RB (2017) The use of hyperbaric oxygen for the prevention and management of osteoradionecrosis of the jaw: a Dana-Farber/Brigham and women’s cancer center multidisciplinary guideline. Oncologist 22(3):343–350

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gorick CM, Chappell JC, Price RJ (2019) Applications of ultrasound to stimulate therapeutic revascularization. Int J Mol Sci 20(12):3081

Article  CAS  PubMed  PubMed Central  Google Scholar 

Madrid C, Abarca M, Bouferrache K (2010) Osteoradionecrosis: an update. Oral Oncol 46(6):471–474

Article  CAS  PubMed  Google Scholar 

Murphy J, Mannion CJ (2020) Medication-related osteonecrosis of the jaws and quality of life: review and structured analysis. Br J Oral Maxillofac Surg 58(6):619–624

Article  CAS  PubMed  Google Scholar 

AlRowis R, Aldawood A, AlOtaibi M, Alnasser E, AlSaif I, Aljaber A, Natto Z (2022) Medication-related osteonecrosis of the jaw (MRONJ): a review of pathophysiology, risk factors, preventive measures and treatment strategies. Saudi Dental J 25:87

Google Scholar 

Vasudev NS, Reynolds AR (2014) Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions. Angiogenesis 17(3):471–494

Article  CAS  PubMed  PubMed Central  Google Scholar 

Garuti F, Camelli V, Spinardi L, Bucci L, Trevisani F (2016) Osteonecrosis of the jaw during sorafenib therapy for hepatocellular carcinoma. Tumori J 102:S69–S70

Article  Google Scholar 

Favia G, Tempesta A, Limongelli L, Crincoli V, Iannone F, Lapadula G, Maiorano E (2017) A case of osteonecrosis of the jaw in a patient with crohn’s disease treated with infliximab. Am J Case Rep 18:1351

Article  PubMed  PubMed Central  Google Scholar 

Singar S, Parihar AP, Reddy P, Maurya A, Bamaniya V (2020) Medication-related osteonecrosis of the jaw: a review about etiology, risk factors, pathophysiology, and treatment. J Indian Acad Oral Med Radiol 32(1):50

Article  Google Scholar 

Aghaloo T, Hazboun R, Tetradis S (2015) Pathophysiology of osteonecrosis of the jaws. Oral Maxillofacial Surg Clin 27(4):489–496

Article  Google Scholar 

Badel T, Savić Pavičin I, Jelinić Carek A, Rošin-Grget K, Grbeša Đ (2013) Pathophysiology of osteonecrosis of the jaw in patients treated with bisphosphonate. Coll Antropol 37(2):645–651

PubMed  Google Scholar 

Chang J, Hakam AE, McCauley LK (2018) Current understanding of the pathophysiology of osteonecrosis of the jaw. Curr Osteoporos Rep 16(5):584–595

Article  CAS  PubMed  Google Scholar 

He L, Sun X, Liu Z, Qiu Y, Niu Y (2020) Pathogenesis and multidisciplinary management of medication-related osteonecrosis of the jaw. Int J Oral Sci 12(1):1–1

Article  Google Scholar 

Qaisi M, Hargett J, Loeb M, Brown J, Caloss R (2016) Denosumab related osteonecrosis of the jaw with spontaneous necrosis of the soft palate: report of a life threatening case. Case Rep Dentistry 28:2016

Google Scholar 

Zhang W, Gao L, Ren W, Li S, Zheng J, Li S, Jiang C, Yang S, Zhi K (2021) The role of the immune response in the development of medication-related osteonecrosis of the jaw. Front Immunol 25(12):438

Google Scholar 

Reid IR, Bolland MJ, Grey AB (2007) Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? Bone 41(3):318–320

Article  CAS  PubMed  Google Scholar 

Peer A, Khamaisi M (2015) Diabetes as a risk factor for medication-related osteonecrosis of the jaw. J Dent Res 94(2):252–260

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim KM, Rhee Y, Kwon YD, Kwon TG, Lee JK, Kim DY (2015) Medication related osteonecrosis of the jaw: 2015 position statement of the Korean society for bone and mineral research and the Korean association of oral and maxillofacial surgeons. J Bone Metabol 22(4):151–165

Article  Google Scholar 

Katz J, Gong Y, Salmasinia D, Hou W, Burkley B, Ferreira P, Casanova O, Langaee TY, Moreb JS (2011) Genetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw. Int J Oral Maxillofac Surg 40(6):605–611

Article  CAS  PubMed  Google Scholar 

AlDhalaan NA, BaQais A, Al-Omar A (2020) Medication-related osteonecrosis of the jaw: a review. Cureus 12:2

Google Scholar 

Poxleitner P, Engelhardt M, Schmelzeisen R, Voss P (2017) The prevention of medication-related osteonecrosis of the jaw. Dtsch Arztebl Int 114(5):63

PubMed  PubMed Central  Google Scholar 

Negrini S, Daleffe F, Audino E, Salgarello S, Castellani A. Surgical treatment of medication-related osteonecrosis of the jaw: technical report and prognosis assessment. Qeios. https://doi.org/10.32388/AWN86A

On SW, Cho SW, Byun SH, Yang BE (2021) Various therapeutic methods for the treatment of medication-related osteonecrosis of the jaw (MRONJ) and their limitations: a narrative review on new molecular and cellular therapeutic approaches. Antioxidants 10(5):680

Article  CAS  PubMed  PubMed Central  Google Scholar